FDA eases nutrition labeling rules for restaurants clearing inventory

To facilitate the distribution of food during the coronavirus pandemic, restaurants and food manufacturers will be temporarily allowed to sell packages of food that lack the Nutrition Facts label normally required for retail sale, said the FDA on Thursday. (No paywall)

FDA mulls ‘risk-based’ approach to CBD products

Americans are consuming the cannabis derivative cannabidiol (CBD) in food, beverages, and supplements, and dosing their pets with it as well, but "there is still much that we do not know about ... potential risks," said FDA commissioner Stephen Hahn on Thursday.

Balance safety, innovation in gene-edited animals, says FDA chief

Gene editing has enormous potential to improve health and food production, but innovation must be governed by well-rooted standards of safety and effectiveness, said FDA Commissioner Stephen Hahn. "The agency is a trusted global regulator and we are committed to overseeing this space in a manner that fosters innovation, protects consumer confidence and protects the public health."

FDA won’t endorse CBD as ‘generally recognized as safe’

In a potential blow to the hottest-selling hemp product, the FDA said it "cannot conclude that CBD (cannabidiol) is generally recognized as safe among qualified experts for its use in human or animal food" because a lack of scientific evidence. The warning came as USDA gathers public comment on a rule that opens the way for nationwide cultivation of industrial hemp in the new year.

Trump chooses cancer doctor to lead FDA

Dr. Stephen Hahn, a hospital executive and cancer specialist, is President Trump's choice for FDA commissioner, said the White House. Hahn had been rumored for the post for weeks. But in a surprise, Health Secretary Alex Azar said FDA's interim leader, Ned Sharpless, would return immediately to his previous post of director of the National Cancer Institute because he had hit a statutory time limit  of 210 days for service as an acting agency chief.

USDA embraces hemp as a crop, but many hurdles remain for growers

At the same time that the agency opened the gate for farmers across the nation to grow industrial hemp in 2020, the USDA tempered optimism about a new, money-making crop on Tuesday with caution of obstacles for an emerging industry. The hottest hemp product, cannabidiol (CBD), is sold in a gray …

Will high risks on industrial hemp bring high rewards?

Industrial hemp faces more regulatory and legal hurdles than many other newly hatched industries, says a report from agricultural lender CoBank. While growth in the industry is driven by cannabidiol (CBD), widely available in foods and as a supplement, two other markets hold potential: the fiber and the grain and seed sectors.

FDA warns against CBD products while working on regulations

Only one drug containing cannabidiol (CBD) has been approved by the FDA — for treatment of rare and severe forms of epilepsy — and the agency is worried by the tide of products that tout CBD as a tonic. The FDA warned against use of unapproved products at the same time it said on Tuesday…

Senate vs. House confrontation looms over relocating ERS and NIFA

The Senate Appropriations Committee is expected to approve a bill on Thursday that effectively approves Agriculture Secretary Sonny Perdue’s removal of two research agencies to Kansas City from Washington, setting up a clash with House leaders. The $151.7 billion USDA-FDA funding bill includes …

Bright hopes, uncertain pace for industrial hemp

The 2018 farm bill legalized the production of industrial hemp and farmers are clearly interested in a potential new cash crop, but many obstacles must be overcome before the industry can take root, said lawmakers and federal regulators on Thursday.